REVB CIK: 1810560

Revelation Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
1.91
FY22:
5.41
FY23:
12.1
FY24:
6.57
FY25:
10.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.13
FY22:
0.09
FY23:
0.07
FY24:
0.06
FY25:
0.77
Total assets
Change from FY21 to FY25
millions USD
FY21:
2.04
FY22:
5.50
FY23:
12.2
FY24:
6.62
FY25:
11.6

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
2.14
FY22:
4.45
FY23:
5.56
FY24:
1.91
FY25:
2.00
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0.72
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.10
FY22:
1.05
FY23:
6.65
FY24:
4.71
FY25:
8.86
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
2.04
FY22:
5.50
FY23:
12.2
FY24:
6.62
FY25:
11.6

All amounts in millions USD Data source:SEC EDGAR